IP Library Granted Patent US 11,083,760
Granted Patent B2
US 11,083,760 · App. 16/519,909 · Granted Aug 10, 2021

Oral microbiota composition for oral and/or sinus infections

Inventor: Shunsheng Han (Los Alamos, NM)
Assignee: Knoze Jr. Corporation
A61K35/744A61K9/0056A61K31/198A61K47/36
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,083,760
App. No.
16/519,909
Granted
Aug 10, 2021
Kind
B2
Abstract

A formulated oral prebiotic edible composition useful for promoting a desired oral microbiota to treat a respiratory allergic condition and/or an oral and/or sinus infection condition in a subject in need of such treatment, the oral prebiotic including comprising L-arginine, the L-arginine including free individual molecules of L-arginine, the free individual molecules of L-arginine L present at a concentration of greater than about 0.1 wt %; a carrier, and a sugar comprising at least one of a monosaccharide and disaccharide; the composition in a configuration suitable to be maintained including being substantially dissolved within the oral cavity for over a period of at least about 1 minute to about an hour, the composition in an effective amount to thereby selectively promote an increased concentration of oral microbiota to thereby treat the respiratory and/or oral and/or sinus related allergy condition, the selected oral microbiota including Veillonella and Streptococcus.

Claims (29)

1. A formulated oral prebiotic edible composition useful for promoting a desired oral microbiota to treat a respiratory allergic condition and/or an oral and/or sinus infection condition in a subject in need of such treatment, the oral prebiotic comprising:

a free amino acid containing ingredient comprising L-arginine, the L-arginine comprising free individual molecules of L-arginine, the free individual molecules of L-arginine L present at a concentration of greater than about 0.1 wt %;

a carrier, and a sugar comprising at least one of a monosaccharide and disaccharide;

at least two distinct live lactic acid probiotics, wherein one is a lactic acid producing bacterium, and one is a lactic acid fermenting bacterium;

wherein the composition is in a configuration suitable to be maintained substantially dissolved within the oral cavity for over a period of at least about 1 minute to about an hour, and wherein the composition is in an effective amount to selectively promote an increased concentration of oral microbiota to treat the respiratory allergic condition and/or an oral and/or sinus infection condition.

2. The composition of claim 1 , wherein the respiratory allergic condition and/or an oral and/or sinus infection condition comprises one or more of gingivitis, periodontitis, tonsillitis, rhinosinusitis, pharyngitis, and laryngitis.

3. The composition of claim 1 , wherein the carrier comprises one or more of a solid, gel, powder or liquid.

4. The composition of claim 1 , wherein the carrier comprises at least one of a solid and gel.

5. The composition of claim 1 , wherein the carrier comprises one or more of a chewable tablet, an edible capsule, a hygienic paste, and an edible food.

6. The composition of claim 1 , wherein the carrier is supported on a bioadhesive strip configured for adhesion within an oral cavity.

7. The composition of claim 1 , wherein the at least one amino acid further comprises at least one of L-cysteine, DL-aspartic acid, L-glutamic acid, L-serine, and L-tyrosine.

8. The composition of claim 1 , wherein the amino acid containing ingredient is present in the composition at a weight percent level of from greater than about 2.4 wt. % to about 99.9 wt. %.

9. The composition of claim 1 , wherein the amino acid containing ingredient is present in the composition at a weight percent level of from about 5.0 wt. % to about 95.0 wt. %.

10. The composition of claim 1 , wherein the sugar further comprises one or more of oligosaccharides, and polysaccharides.

11. The composition of claim 10 , wherein the sugar comprises one or more of mannose, lactose, malibiose, maltose, cellobiose, trehalose, raffinose.

12. The composition of claim 10 , wherein the composition further comprises polysaccharide polymers.

13. The composition of claim 12 , wherein the polysaccharide polymers comprise one or more of pullulan and inulin.

14. The composition of claim 10 , wherein the sugar comprises one or more of rhamnose, xylitol, arabitol, fructose, glucose, inositol, sucrose, and maltose.

15. The composition of claim 10 , wherein the sugar is present in the composition at a weight percent level of from about greater than about 0.1 wt. % to about 95 wt. %.

16. The composition of claim 10 , wherein the sugar is present in the composition at a weight percent level of from about 0.5 wt. % to about 95 wt. %.

17. The composition of claim 10 , wherein the sugar is present in the composition at a weight percent level of from about 5.0 wt. % to about 95.0 wt. %.

18. The composition of claim 1 , wherein at least one of the composition and oral cavity further comprises live bacteria comprising lactic acid producing bacteria and lactic acid fermenting bacteria at a level of from about 1000 to about 1,000,000,000 living cells.

19. The composition of claim 1 , wherein the lactic acid producing bacterium includes one or more Streptococcus subspecies and wherein the lactic acid fermenting bacterium comprises one or more Veillonella subspecies.

20. A method of using a formulated oral prebiotic edible composition for promoting a desired oral microbiota to treat a respiratory allergic condition and/or an oral and/or sinus infection condition in a subject in need of such treatment comprising:

providing the composition comprising:

a free amino acid containing ingredient comprising L-arginine, the L-arginine comprising free individual molecules of L-arginine, the free individual molecules of L-arginine present at a concentration of greater than about 0.1 wt %;

a carrier and a sugar comprising at least one of a monosaccharide and disaccharide; and

at least two distinct live lactic acid probiotics, wherein one is a lactic acid producing bacterium, and one is a lactic acid fermenting bacterium;

wherein the composition is maintained within the oral cavity including being substantially dissolved over a period of at least about 1 minute to about an hour to provide the free individual molecules of L-arginine in an effective amount to promote an increased concentration of selected oral microbiota to treat the respiratory allergic condition and/or an oral and/or sinus infection condition.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 23, 2019
From: HAN, SHUNSHENG
To: KNOZE JR. CORPORATION
Reel/Frame 049836/0788 →
Continuity (3)
Continuation In Part 15706323 · Sep 15, 2017
Continuation In Part 15495188 · Apr 24, 2017
Related Publication 20190343900A1 · Nov 14, 2019
Cited By (8)
US 12,246,043 US 12,257,272 US 12,279,989 US 12,318,411 US 12,318,414 US 12,329,783 US 12,357,662 US 12,533,312